Progressive multifocal leukoencephalopathy in patients treated with chimeric antigen receptor T cells
Blood · 09.02.2023 · 141 (6) · 673-677
DOI: 10.1182/blood.2022017386 ↗Kurz gefasst
Fachartikel in der Zeitschrift Blood, erschienen am 09.02.2023. Verfasst von Adam Goldman und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, The Talpiot Sheba Medical Leadership Program, Chaim Sheba Medical Center, Ramat-Gan, Israel. Hauptthemen laut MEDLINE: Leukoencephalopathy, Progressive Multifocal, Receptors, Chimeric Antigen. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Using 2 global postmarketing surveillance databases, Goldman and colleagues report that progressive multifocal leukoencephalopathy (PML), a viral disease associated with profound immunosuppression, occurs in approximately 0.9 cases per 1000 recipients of CD19-directed CAR T-cell therapy. The risk of PML appears higher with CAR T-cell therapy than other cancer therapies, but its precise role cannot be distinguished from antecedent therapies that these patients receive.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, The Talpiot Sheba Medical Leadership Program, Chaim Sheba Medical Center, Ramat-Gan, Israel.
- Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
- Pharmacology Unit, Department of Medical and Surgical Sciences, Alma Mater Studiorum - University of Bologna, Bologna, Italy.
- Department of Neurology, The Chaim Sheba Medical Center, Ramat-Gan, Israel.
- Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY.
- Adult Bone Marrow Transplantation Service and Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY.
ORCID-Profile: Adam Goldman, Emanuel Raschi, Marcelo C Pasquini, Miguel-Angel Perales, Roni Shouval
Förderung
- NCI NIH HHS
Zitieren
APA
Goldman, A., Raschi, E., Chapman, J., Santomasso, B. D., Pasquini, M. C., Perales, M. A., & Shouval, R. (2023). Progressive multifocal leukoencephalopathy in patients treated with chimeric antigen receptor T cells. Blood, 141(6), 673-677. https://doi.org/10.1182/blood.2022017386
Vancouver
Goldman A, Raschi E, Chapman J, Santomasso BD, Pasquini MC, Perales MA, et al. Progressive multifocal leukoencephalopathy in patients treated with chimeric antigen receptor T cells. Blood. 2023;141(6):673-677. doi:10.1182/blood.2022017386
BibTeX
@article{Goldman2023,
author = {Goldman, Adam and Raschi, Emanuel and Chapman, Joab and Santomasso, Bianca D and Pasquini, Marcelo C and Perales, Miguel-Angel and Shouval, Roni},
title = {Progressive multifocal leukoencephalopathy in patients treated with chimeric antigen receptor T cells},
journal = {Blood},
year = {2023},
volume = {141},
number = {6},
pages = {673--677},
doi = {10.1182/blood.2022017386}
}
EUVIMED